Loading insider details...
Beta
Latest Form 4 (Sep 2, 2026): Grant/Award of 1,159 BCRX shares, $11.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 2, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 1,159 | $11.2K |
| Jun 15, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 15,294 | n/a |
| Jun 8, 2026 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 11,580 | n/a |
| Jun 2, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 1,122 | $10.0K |
| Mar 3, 2026 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 848 | $7.4K |
| Dec 2, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 783 | $5.6K |
| Sep 3, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 676 | $5.6K |
| Jun 16, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 12,500 | n/a |
| Jun 9, 2025 | Aclaris Therapeutics, Inc. (ACRS) | Exercise/Conversion | 4,793 | n/a |
| Jun 3, 2025 | BIOCRYST PHARMACEUTICALS INC (BCRX) | Grant/Award | 523 | $5.6K |